CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,172,000 | -39.3% | 432,600 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $1,930,000 | -23.1% | 432,600 | 0.0% | 0.02% | -11.1% |
| Q2 2021 | $2,510,000 | -52.2% | 432,600 | -42.2% | 0.02% | -57.1% |
| Q1 2021 | $5,254,000 | +95.9% | 748,400 | +33.9% | 0.04% | +250.0% |
| Q4 2020 | $2,682,000 | -17.7% | 558,800 | 0.0% | 0.01% | -40.0% |
| Q3 2020 | $3,258,000 | +387.7% | 558,800 | +464.4% | 0.02% | +233.3% |
| Q2 2020 | $668,000 | +77.2% | 99,000 | +174.2% | 0.01% | +50.0% |
| Q4 2019 | $377,000 | -72.7% | 36,100 | -89.7% | 0.00% | -71.4% |
| Q3 2019 | $1,380,000 | – | 351,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |